A Study to Evaluate the Effect of Hepatic Impairment on Lazertinib (JNJ-73841937)
Clinical trial NCT05112952 · COMPLETED
Trial details
- NCT number
- NCT05112952
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2022-07-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.